OOIR: Observatory of International Research

Papers

(The TQCC of Internal Medicine Journal is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Non‐alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management	114
How COVID‐19 has pushed us into a medical education revolution	75
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study	68
Telehealth in cancer care: during and beyond the COVID‐19 pandemic	59
Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021	52
Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID‐19: a systematic review	44
Health status and healthcare trends of individuals accessing Australian aged care programmes over a decade: the Registry of Senior Australians historical cohort	41
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021	40
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic	35
Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID‐19 pandemic in Australia	34
Nursing homes: the titanic of cruise ships – will residential aged care facilities survive the COVID‐19 pandemic?	31
Portopulmonary hypertension: prognosis and management in the current treatment era – results from the REHAP registry	30
Effect of the COVID‐19 induced phase of massive telehealth uptake on end‐user satisfaction	29
Idiopathic inflammatory myopathies: a review	29
2004 chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative study	28
Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021	27
Machine learning in the prediction of medical inpatient length of stay	26
Immunosuppression as a risk factor for COVID‐19: a meta‐analysis	26
Quality of care in inflammatory bowel disease: actual health service experiences fall short of the standards	25
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant reci	25
Evaluation of the effect of COVID‐19 pandemic on anxiety severity of physicians working in the internal medicine department of a tertiary care hospital: a cross‐sectional survey	24
Advance care planning in Australia during the COVID‐19 outbreak: now more important than ever	23
An overview of healthcare improvement: unpacking the complexity for clinicians and managers in a learning health system	21
Utilisation of telehealth for outpatient diabetes management during COVID‐19 pandemic: how did the patients fare?	21
Autoimmune hepatitis triggered by COVID‐19	21

Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021	20
Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021	20
Telehealth model of care for outpatient inflammatory bowel disease care in the setting of the COVID‐19 pandemic	20
COVID‐19‐associated collapsing glomerulopathy: a report of two cases and literature review	19
Possible role of hypothyroidism in the prognosis of COVID‐19	19
COVID‐19 vaccine hesitancy: a unique set of challenges	18
Frailty and mortality associations in patients with COVID‐19: a systematic review and meta‐analysis	18
Pill testing at music festivals: is it evidence‐based harm reduction?	18
Patient preferences using telehealth during the COVID‐19 pandemic in four Victorian tertiary hospital services	17
Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19	17
VEXAS syndrome: lessons learnt from an early Australian case series	17
Workplace stress, common mental disorder and suicidal ideation in junior doctors	17
Help‐seeking for depression among Australian doctors	17
Gender equity within medical specialties of Australia and New Zealand: cardiology's outlier status	17
Demystifying machine learning: a primer for physicians	17
Nitrous oxide‐induced neurological disorders: an increasing public health concern	16
Oral health and cardiometabolic disease: understanding the relationship	16
Systematic review of medical education on spirituality	16
Beneficial effect of awake prone position in hypoxaemic patients with COVID‐19: case reports and literature review	15
Anti‐MDA5‐associated dermatomyositis	15
Deprescribing long‐term opioid therapy in patients with chronic pain	15
Renin–angiotensin system inhibition and risk of infection and mortality in COVID‐19: a systematic review and meta‐analysis	15
Clinical efficacy and plausibility of a smartphone‐based integrated online real‐time diabetes care system via glucose and diet data management: a pilot study	15
Poor access to kidney disease management services in susceptible patient populations in rural Australia is associated with increased aeromedical retrievals for acute renal care	15
Low serum albumin levels predict short‐ and long‐term mortality risk in patients hospitalised to general surgery wards	14
Geriatric nutritional risk index is associated with mortality in peritoneal dialysis patients	14
Energy drinks: a narrative review of their physiological and pathological effects	14
Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021	14
Temporal trends in the burden of heart failure	14
Renal manifestations of syphilis	14
Novel ENT triad of anosmia, ageusia and hearing impairment in COVID‐19	14
Catheter‐related thrombosis incidence and risk factors in adult cancer patients with central venous access devices	14
Comparison of clinical manifestation among Australian Indigenous and non‐indigenous patients presenting with pleural effusion	14
Impact of Gaucher disease on COVID‐19	14
Adult‐onset Still disease post‐adenovirus vector COVID‐19 vaccine	14
Frailty in chronic kidney disease: challenges in nephrology practice. A review of current literature	14
Central sensitivity and fibromyalgia	14
Congenital long QT syndrome: a clinician's guide	13
Assessment of respiratory function and exercise tolerance at 4–6 months after COVID‐19 infection in patients with pneumonia of different severity	13
Monitoring skin temperature at the wrist in hospitalised patients may assist in the detection of infection	13
Support for and willingness to be involved in voluntary assisted dying: a multisite, cross‐sectional survey study of clinicians in Victoria, Australia	13
Heterogeneity in patterns of progression of chronic kidney disease	12
Prevalence of polycythaemia with different formulations of testosterone therapy in transmasculine individuals	12
Silent suffering of the dying and their families: impact of COVID‐19	12
Decreases in cardiac catheter laboratory workload during the COVID‐19 level 4 lockdown in New Zealand	12
Multidisciplinary quality improvement programme for older patients admitted to a vascular surgery ward^*	12
Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid‐range and reduced ejection fraction	12
Enterococcal bacteraemia ‘silent but deadly’: a population‐based cohort study	12
Rheumatoid arthritis is a preventable disease: 11 ways to reduce your patients' risk	12
Six‐month respiratory outcomes and exercise capacity of COVID‐19 acute respiratory failure patients treated with continuous positive airway pressure	12

Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis	12
Direct oral anticoagulants for cancer‐associated venous thromboembolisms: a systematic review and network meta‐analysis	12
Reducing medication errors for hospital inpatients with Parkinsonism	11
Treatment use and satisfaction in Australian women with endometriosis: a mixed‐methods study	11
COVID‐19 vaccination in haematology patients: an Australian and New Zealand consensus position statement	11
Ambiguous medical abbreviation study: challenges and opportunities	11
COVID‐19 end‐of‐life care: symptoms and supportive therapy use in an Australian hospital	11
Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals	11
Don't forget shared decision‐making in the COVID‐19 crisis	11
Communicating prognostic information: what do oncologists think patients with incurable cancer should be told?	11
COVID‐19 and future pandemics: is isolation and social distancing the new norm?	11
Real‐world direct oral anticoagulant experience in atrial fibrillation: falls risk and low dose anticoagulation are predictive of both bleeding and stroke risk	11
Endovascular clot retrieval for M2 segment middle cerebral artery occlusion: a systematic review and meta‐analysis	11
Systematic review and meta‐analysis of the characteristics and outcomes of readmitted COVID‐19 survivors	11
Incident atrial fibrillation in patients undergoing bariatric surgery: a systematic review and meta‐analysis	11
Oral amoxicillin challenge for low‐risk penicillin allergic patients	11
Comparison of the effects of oral iron treatment every day and every other day in female patients with iron deficiency anaemia	11
Model‐based analysis on systemic availability of co‐administered cannabinoids after controlled vaporised administration	11
Risk factors for pregnancy outcomes in Type 1 and Type 2 diabetes	11
Optimising the response to acute clinical deterioration: the role of observation and response charts	10
Education to improve vancomycin use: the perspectives of educators and education recipients	10
Predictors of a long length of stay in the emergency department for older people	10
Nivolumab‐associated myositis myocarditis and myasthenia and anti‐striated muscle antibodies	10
Pilot study of a machine‐learning tool to assist in the diagnosis of hand arthritis	10
Treatable lysosomal storage diseases in the advent of disease‐specific therapy	10
Increasing Helicobacter pylori clarithromycin resistance in Australia over 20 years	10
Current approach to acute stroke management	10
Charlson comorbidity index scores and in‐hospital prognosis of patients with severe acute respiratory infections	10
Effectiveness of patient‐oriented education and medication management intervention in people with decompensated cirrhosis	10
Classification and analysis of outcome predictors in non‐critically ill COVID‐19 patients	10
Specificity of serum amyloid A as a biomarker of idiopathic pulmonary fibrosis	10
Presenting symptoms of COVID‐19 and clinical outcomes in hospitalised older adults	10
Practical management of inflammatory bowel disease patients during the COVID‐19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease	10
Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID‐19	10
Residential aged care facility COVID‐19 outbreaks and magnitude of spread among residents: observations from a Victorian residential in‐reach service	10
Towards new models of cancer care in Australia: lessons from Victoria's response to the COVID‐19 pandemic	9
The health impacts of ambient air pollution in Australia: a systematic literature review	9
Utility of ⁶⁸Ga‐DOTA‐Exendin‐4 positron emission tomography–computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endog	9
Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021	9
Burden of infective endocarditis in an Australian cohort of people who inject drugs	9
Incorporating the Clinical Frailty Scale into routine outpatient nephrology practice: an observational study of feasibility and associations	9
Telehealth in outpatient delivery of palliative care: a prospective survey evaluation by patients and clinicians	9
Just ‘nanging’ around – harmful nitrous oxide use: a retrospective case series and review of Internet searches, social media posts and the coroner's database	9
Prevalence and risk factors of ischaemic stroke in the young: a regional Australian perspective	9
Telehealth in Australian cardiology: insight into factors predicting the use of telephone versus video during the COVID‐19 pandemic	9
Community‐based management of complex type 2 diabetes: adaptation of an integrated model of care in a general practice setting	9
Clinical leadership development in Australian healthcare: a systematic review	9
Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non‐small‐cell lung cancer in New Zealand	9
Febuxostat as a renoprotective agent for treatment of hyperuricaemia: a meta‐analysis of randomised controlled trials	9
Mental health illness in chronic respiratory disease is associated with worse respiratory health and low engagement with non‐pharmacological psychological interventions	9
Understanding vaccine‐induced thrombotic thrombocytopenia (VITT)	9
Mobile applications for the management of chronic physical conditions: a systematic review	9
Prognostic significance of suboptimal secondary prevention pharmacotherapy after acute coronary syndromes	9
Novel renal biomarkers of acute kidney injury and their implications	9
Psychosocial burden of inflammatory bowel disease in adolescents and young adults	9
Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost‐savings	9
Obstructive sleep apnoea and adherence to continuous positive airway therapy among Australian women	9
Antithrombin III as predictive indicator of survival in idiopathic pulmonary fibrosis (IPF) patients treated with nintedanib: a preliminary study	9
Trends in stroke reperfusion treatment and outcomes in New Zealand	9
Scoring system to facilitate diagnosis of Gaucher disease	9
Aeromedical retrieval diagnostic trends during a period of Coronavirus 2019 lockdown	9
Clinical characteristics and outcomes of critically ill patients with one, two and three doses of vaccination against COVID‐19 in Australia	8
Erzhu Qinggan Jiedu Recipe improves the clinical outcome of hepatocellular cancer after surgical resection: a case–control retrospective study	8
Osmotic demyelination syndrome: novel risk factors and proposed pathophysiology	8
Planning and clinical role of acute medical home care services for COVID‐19: consensus position statement by the Hospital‐in‐the‐Home Society Australasia	8
Industry payments to Australian medical oncologists and clinical haematologists: a cross‐sectional analysis of publicly available disclosures	8
Predictors of real‐world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone‐sensitive prostate cancer	8
Neurotoxicity in chronic lithium poisoning	8
Guillain–Barré syndrome: clinical features, treatment choices and outcomes in an Australian cohort	8
Idiopathic granulomatous mastitis: case series and clinical review	8
Accessible and affordable healthcare? Views of Australians with and without chronic conditions	8
The workplace and psychosocial experiences of Australian junior doctors during the COVID‐19 pandemic	8
Complications of cardiac implantable electronic device placement in public and private hospitals	8
Admission sodium levels and hospital outcomes	8
Antimicrobial stewardship audit and feedback rounds: the impact of electronic systems and moving beyond the restricted antibiotic list	8
Addressing the challenges of artificial intelligence in medicine	8
Negative media portrayal of palliative care: a content analysis of print media prior to the passage of Voluntary Assisted Dying legislation in Victoria	8
Telehealth in the time of Corona: ‘doctor in the house’	8
Cannabis: are there any benefits?	8
Application of Thyroid Imaging Reporting and Data System (TIRADS) guidelines to thyroid nodules with cytopathological correlation and impact on healthcare costs	8

Hospital‐in‐the‐Home experience of first 23 COVID‐19 patients at a regional NSW hospital	8
Developing a framework for implementing opioid stewardship programmes in Australian hospital settings	7
Impact of COVID‐19 on an Australian intensive care unit: lessons learned from South Australia	7
Flexible bronchoscopy indications and outcomes between indigenous and non‐indigenous patients in the Northern Territory of Australia	7
Pharmacists reducing medication risk in medical outpatient clinics: a retrospective study of 18 clinics	7
Evaluation of pleural fluid cytology for the diagnosis of malignant pleural effusion: a retrospective cohort study	7
Hospitalised exacerbations of chronic obstructive pulmonary disease: adherence to guideline recommendations in an Australian teaching hospital	7
All‐cause unplanned readmissions in the United States: insights from the Nationwide Readmission Database	7
Evaluation of patient satisfaction for telehealth (telephone and video) in rheumatology outpatients during COVID‐19 pandemic	7
Adherence to guidelines regarding anticoagulation and risk factors for progression of atrial fibrillation in a nurse‐led clinic	7
Glycaemic control across the lifespan in a cohort of New Zealand patients with type 1 diabetes mellitus	7
Impact of Victoria's first dedicated endocrine hypertension service on the pattern of primary aldosteronism diagnoses	7
Content analysis of euthanasia polls in Australia and New Zealand: words do matter	7
Development and dissemination of the national strategic action plan for reducing inappropriate polypharmacy in older Australians	7
Self‐reported child maltreatment and cardiometabolic risk in 30‐year‐old adults	7
Business as unusual: medical oncology services adapt and deliver during COVID‐19	7
Global Burden of Disease Study 2019: an opportunity to understand the growing prevalence and impact of hip, knee, hand and other osteoarthritis in Australia	7
Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy	7
Documentation of adverse drug reactions to opioids in an electronic health record	7
Effectiveness of a locality‐based integrated diabetes care service on clinical outcomes	7
Coronavirus disease 2019 (COVID‐19): not one epidemic but four	7
The Australian burden of invasive group A streptococcal disease: a narrative review	7
Impact of fast‐food outlet density on incidence of myocardial infarction in the Hunter region	7
Use of a limited‐channel device for obstructive sleep apnoea diagnosis in a tertiary sleep disorders centre	7
Prion disease in Indigenous Australians	7
Clinical, psychological and demographic factors in a contemporary adult cohort with diabetic ketoacidosis and type 1 diabetes	7
Where are our patients? Retrospective cohort study of acute medical unit admissions during and prior to the COVID‐19 pandemic	7
Analysing triggers for anti‐NMDA‐receptor encephalitis including herpes simplex virus encephalitis and ovarian teratoma: results from the Queensland Autoimmune Encephalitis cohort	7
Our dementia challenge: arise palliative care	7
Acquired haemophilia and haemostatic control with recombinant porcine factor VIII: case series	7
COVID‐19 in the pre‐pandemic period: a survey of the time commitment and perceptions of infectious diseases physicians in Australia and New Zealand	7
Risk factors for readmission following inpatient management of COVID‐19 in a low‐prevalence setting	7
Death, dying and donation: community perceptions of brain death and their relationship to decisions regarding withdrawal of vital organ support and organ donation	7
Medical student knowledge and critical appraisal of machine learning: a multicentre international cross‐sectional study	7
Treatment and outcomes for indigenous and non‐indigenous lung cancer patients in the Top End of the Northern Territory	7
Exercise testing and exercise training within cystic fibrosis centres across Australia and New Zealand: what is considered important and what is current practice?	7
Acute pulmonary embolism in patients presenting pulmonary deterioration after hospitalisation for non‐critical COVID‐19	7
COVID‐19 pandemic and the tension between the need to act and the need to know	6
Rapid implementation of telehealth in geriatric outpatient clinics due to COVID‐19	6
Population‐based analysis of radiotherapy and chemotherapy treatment in the last month of life within regional Australia	6
Rapid response team trigger modifications: are we using them safely?	6
COVID‐19 restrictions should only be lifted when it is safe to do so for Aboriginal communities	6
Observational study of peripheral intravenous catheter outcomes in an internal medicine department	6
Efficacy of methotrexate in polymyalgia rheumatica in routine rheumatology clinical care	6
Specialist haematology consultation services in regional Western Australia: evaluating a model combining telehealth and onsite clinics	6
Lupus nephritis in Indigenous Australians: a single‐centre study	6
Use of telehealth to increase treatment access for prisoners with chronic hepatitis C	6
Consensus guidelines for improving patients' understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021	6
Carbon emissions and hospital pathology stewardship: a retrospective cohort analysis	6
Prescription trends and costs of diabetes medications in Australia between 2003 and 2019: an analysis and review of the literature	6
Prevalence of drug allergy in South Australia	6
Results from a double blinded, randomised, placebo‐controlled, feasibility trial of melatonin for the treatment of delirium in older medical inpatients	6
Practical ethical challenges and moral distress among staff in a hospital COVID‐19 screening service	6
Penicillin Allergy Delabeling Program: an exploratory economic evaluation in the Australian context	6
Performance of risk models predicting cardiac complications in pregnant women with congenital heart disease: a meta‐analysis	6
Outcomes of community‐based hepatitis C treatment by general practitioners and nurses in Australia through remote specialist consultation	6
Prescribing direct‐acting antivirals to treat hepatitis C virus in a general practice setting in Australia: ‘so why not do it’?	6
Frailty status, timely goals of care documentation and clinical outcomes in older hospitalised medical patients	6
Desmopressin acetate to prevent bleeding in percutaneous kidney biopsy: a systematic review	6
A nationwide survey on therapeutic drug monitoring of anti‐tumour necrosis factor agents for inflammatory bowel disease	6
Cannabis, cannabidiol and tetrahydrocannabinol in sport: an overview	6
Evidence‐practice gaps in P2Y₁₂ inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population‐level data linkage in Australia	6
Real‐world off‐label use of icatibant for acute management of non‐hereditary angioedema	6
Longitudinal prevalence of inpatient diabetes mellitus in an Australian hospital across five decades: 1972–2019	6
Scleroderma in Cairns: an epidemiological study	6
Peritoneal dialysis‐related peritonitis as a risk factor for cardiovascular events	6
Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance	6
Helicobacter pylori antimicrobial resistance in Melbourne, Australia. Time to review therapeutic guidelines?	6
The gut microbiota and gut disease	6
The application of telehealth to remote and rural Australians with chronic neurological conditions	6
Real‐world opioid prescription to patients with serious, non‐malignant, respiratory illnesses and chronic breathlessness	6
Lung, breast and bowel cancer treatment for Aboriginal people in New South Wales: a population‐based cohort study	6
Bortezomib use and outcomes for the treatment of multiple myeloma	6
Incidence and predictors of idiopathic pulmonary fibrosis complicating Type 2 diabetes: the Fremantle Diabetes Study Phase I	6
Use of indwelling pleural/peritoneal catheter in the management of malignant ascites: a retrospective study of 48 patients	6
Impact of subclinical hypothyroidism on health‐related quality of life: a narrative review	6
Tolerability and efficacy of sacubitril/valsartan in clinical practice	6
Prevalence and distribution of functional splenic tissue after splenectomy	6
Myocardial perfusion imaging failed to improve patient risk classification compared with the revised cardiac risk index for early cardiac complications after major non‐cardiac surgery	6
Medical and surgical treatment of thyroid eye disease	6
COVID‐19 pandemic: end‐of‐life experience in Australian residential aged care facilities	6
Introducing 1,3‐beta‐d‐glucan for screening and diagnosis of invasive fungal diseases in Australian high‐risk haematology patients: is there a clinical benefit?	6
Comparison of high‐flow and conventional nasal cannula oxygen in patients undergoing endobronchial ultrasonography	6
Relationship between residual kidney function and symptom burden in haemodialysis patients	6
Pulmonary function testing for the early detection of drug‐induced lung disease: a systematic review in adults treated with drugs associated with pulmonary toxicity	6
Low mortality in vaccinated immunocompromised haematology patients infected with SARS‐CoV‐2	5
Ventilation perfusion lung SPECT/CT in pregnancy during COVID‐19	5
Do health service staff support the implementation of voluntary assisted dying at their workplace?	5
The quest to reduce stroke treatment delays at a Melbourne metropolitan primary stroke centre over the past two decades	5
Predictors of bleeding in patients receiving direct oral anticoagulants	5
Australian public hospital inpatient satisfaction related to early patient involvement and shared decision‐making in discharge planning	5
Trends in practice: attitudes and challenges in the diagnosis, treatment and management of HIV infection in Australia	5
Lung cancer screening in Australia and New Zealand: the evidence and the challenge	5
Safety and efficacy of high‐flow nasal cannula therapy in acute hypercapnic respiratory failure: a retrospective audit	5
Unbound vitamin D concentrations are not decreased in critically ill patients	5